Indoco Remedies Limited share price
NSE: INDOCO · ISIN INE873D01024
Key numbers
- Market cap
- ₹ 2,345 Cr
- Current price
- ₹ 254.46
- 52-week high / low
- ₹ 317 / 162
- Stock P/E
- 348.6
- Book value
- ₹ 111.6
- Dividend yield
- 0.08%
- ROCE
- 0.8%
- ROE
- -9.7%
- Debt to equity
- 1.16
- Sales growth (3 yrs)
- 3.0%
- Profit growth (3 yrs)
- -
- 1-year return
- -15.9%
About Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, extractables and leachables studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services,…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 431 | 472 | 434 | 456 | 466 |
| Operating profit | 18 | 43 | 32 | 50 | 41 |
| Net profit | -36 | -8 | -30 | -22 | 65 |
| EPS (₹) | -3.94 | -1.00 | -3.20 | -2.57 | 7.09 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.